ABBVIE INC. (ABBV)
Health Care ยท Pharmaceutical Preparations
ABBVIE INC. (ABBV) is listed on the New York Stock Exchange, where its shares have traded since December 10, 2012. SentiSense covers ABBVIE INC. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Robert A. Michael is its chief executive officer. The company reports 57,000 employees, and its corporate website is www.abbvie.com.
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Latest reported results
AbbVie Inc. reported revenue of $16.99 billion for Q2 FY2026, up 10.2% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 4,143 institutions reported holding ABBV, with 1.3 billion shares worth $330.8 billion in aggregate. The largest reported holders were Vanguard, BlackRock and State Street. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on ABBV
- ABBV sentiment: whether news and social coverage of ABBVIE INC. leans bullish or bearish, and the stories driving it.
- ABBV ownership: all 4,143 reporting institutions, plus insider and congressional trades.
- ABBV financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for ABBVIE INC.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does ABBVIE INC. do?
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta).
What sector is ABBV in?
SentiSense classifies ABBVIE INC. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ABBV stock trade?
ABBVIE INC. (ABBV) is listed on the New York Stock Exchange, where its shares have traded since December 10, 2012.
Who is the CEO of ABBVIE INC.?
Robert A. Michael is the chief executive officer of ABBVIE INC..